Primary Hypothesis:
Immunization with live, attenuated (Oka/Merck) varicella-zoster vaccine will significantly reduce the burden of illness associated with herpes zoster (HZ).
Secondary Hypotheses:
Immunization with live, attenuated (Oka/Merck) varicella-zoster vaccine will reduce the incidence of